TransMedics Group
Toronto, Canada · Biotechnology, Healthcare, Health Care
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the uti
Key facts
- Headquarters
- Toronto, Canada
- Employees
- 636
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Public (TMDX)
- Website
- transmedics.com
- Company page
Recent activity at TransMedics Group
- : TransMedics Appoints Fernando Araujo as Chief Financial Officer
- : SEC 8-K (5.02): On September 10, 2026, TransMedics Group, Inc. appointed Fernando Araujo as Chief Financial Officer and Treasurer, effective September 21, 2026. He succeeds Gerardo Hernandez, who held the position since 2024. Mr. Araujo, age 46, has a strong financial background, having served as Chief Financial Officer for GE Health Care's Advanced Imaging Solutions from 2023 to 2026, and positions at 3M and GE before that. His employment includes an annual base salary of $590,000 and a bonus opportunity, with significant severance benefits in the event of a qualifying termination after 12 months of employment. This transition is expected to enhance the financial leadership of the Company.
- : TransMedics Appoints New Chief Commercial Officer and General Counsel
- : SEC 8-K (5.02): On February 1, 2026, TransMedics Group, Inc. appointed Giovanni Cecere as Chief Commercial Officer, effective February 2, 2026, succeeding Tamer Khayal, M.D., who will transition to Senior Vice President of International. Additionally, Matthew Forsyth was appointed as Senior Vice President, General Counsel & Corporate Secretary, effective March 9, 2026. This appointment follows the transition of Anil Ranganath to a non-executive position; Ranganath will continue to receive his current salary and a bonus until his Separation Date on June 7, 2026. Significant financial implications include Ranganath's transitional compensation and ongoing equity vesting, along with a $10,000 annual consulting fee post-transition, underlining the strategic importance of these leadership changes for the company's future direction.
- : SEC 8-K (5.02): On February 1, 2026, TransMedics Group, Inc. appointed Giovanni Cecere as the new Chief Commercial Officer, effective February 2, 2026. He succeeds Tamer Khayal, M.D., who has been with the company since January 2018 and will now serve as Senior Vice President of International, also effective February 2, 2026. Additionally, Matthew Forsyth has been appointed as Senior Vice President, General Counsel & Corporate Secretary, effective on March 9, 2026, or the first date of his employment. These leadership changes aim to enhance the operational strategy of the company moving forward.
- : SEC 8-K (1.01):
- : TransMedics Group, Inc. launched a dedicated organ transportation logistics network in collaboration with Mercedes-Benz.
- : TransMedics Appoints Gerardo Hernandez as Chief Financial Officer, Succeeding Stephen Gordon
- : CIBC Innovation Banking Appoints Paul McKinlay and Patrick Martin as Executive Managing Directors and Co-Heads
- : Transmedics Completes Acquisition Of Summit Aviation
TransMedics Group funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2022 | Debt Financing | $60.0M |
| Sep 2015 | Venture | $500K |
| Jun 2015 | Venture | $63.7M |
Leadership
- Waleed Hassanein, President & CEO
- James Gilbert, Director
- Edward Basile, Director
- Dmitry Kobyzev, Director
- David Abrams, Director
- Travis Rhodes, Director
- James Tobin, Director
- Edwin Jr., Director
- Waleed Hassanein, Executive Officer, Director
- Fernando Araujo, Chief Financial Officer
- Tamer Khayal, Senior Vice President
- Giovanni Cecere, Chief Commercial Officer
Verified email and direct lines for TransMedics Group’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
TransMedics Group in the news
- TransMedics Group, Inc. (TMDX) Stock Price, News, Quote & History - Yahoo! Finance Canada (Oct 21, 2026)
- TransMedics Reports Second Quarter 2026 Financial Results - PR Newswire (Aug 04, 2026)
- Earnings call transcript: TransMedics Q2 2026 revenue rises, but EPS misses - Investing.com (Aug 04, 2026)
- TransMedics announces new HQ, expansion in Massachusetts - MassDevice (Jan 12, 2026)
- TransMedics Reports First Quarter 2026 Financial Results - PR Newswire (May 05, 2026)
- TransMedics Group (TMDX) Stock Rises on Q2 2026 Earnings - Quiver Quantitative (Aug 04, 2026)
- TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH - PR Newswire (Jul 06, 2026)
- TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX - Morningstar (Aug 29, 2026)
Companies similar to TransMedics Group
- InspireMD · Biotechnology, Healthcare, Health Care, Manufacturing, Medical Device
- Shape Memory Medical · Biotechnology, Healthcare, Health Care, Manufacturing, Medical Device
- NOWDiagnostics, Inc. · Biotechnology, Healthcare, Health Care, Manufacturing, Medical Device
- CurvaFix · Biotechnology, Healthcare, Health Care, Manufacturing, Medical Device
- Tenon Medical · Biotechnology, Healthcare, Health Care, Manufacturing, Medical Device
About TransMedics Group: questions and answers
What does TransMedics Group do?
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the uti
Where is TransMedics Group headquartered?
TransMedics Group is headquartered in Toronto, Canada.
How many employees does TransMedics Group have?
TransMedics Group has about 636 employees.
Has TransMedics Group raised funding?
Yes. Fundz has recorded 3 funding events for TransMedics Group. The most recent, Debt Financing of $60.0M, was in Sep 2022.
Who leads TransMedics Group?
Waleed Hassanein is a President & CEO at TransMedics Group.
What is the latest news on TransMedics Group?
On Sep 10, 2026, TransMedics Appoints Fernando Araujo as Chief Financial Officer
Is TransMedics Group a public company?
Yes. TransMedics Group is publicly traded under the ticker TMDX.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy